Ah0003 50450

Palo Alto, California 94303

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) — Completed